NEW YORK (GenomeWeb News) – A White House advisory panel today recommended that any researchers, clinicians, and direct-to-consumer firms that generate genomic, imaging, or other types of biomedical data should plan to encounter incidental findings and should communicate with patients, study participants, and consumers about how these findings will be handled.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.